DELCATH SYSTEMS INC (DCTH)       3.3  +0.03 (+0.92%)

3.3  +0.03 (+0.92%)

US24661P8077 - Common Stock

News Image
25 days ago - Delcath Systems, Inc.

Delcath Systems to Participate at the H.C. Wainwright 24th Annual Global Investor Conference on September 12 and 13, 2022

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

News Image
2 months ago - Delcath Systems, Inc.

Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

News Image
2 months ago - BusinessInsider

Delcath Systems to Host Second Quarter 2022 Results

NEW YORK, July 27, 2022 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of prima...

News Image
2 months ago - Delcath Systems, Inc.

Delcath Systems to Host Second Quarter 2022 Results

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

News Image
2 months ago - Delcath Systems, Inc.

Delcath Systems to Present at Upcoming Investor Conferences in August

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

News Image
2 months ago - Market News Video

Thursday 7/21 Insider Buying Report: KDP, DCTH

News Image
2 months ago - Delcath Systems, Inc.

Delcath Systems Closes Private Placement of $5.0 Million

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

News Image
2 months ago - Delcath Systems, Inc.

Delcath Systems Announces Private Placement of $5.0 Million

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

News Image
4 months ago - Delcath Systems, Inc.

Positive Initial Results from CHOPIN Phase 1b Trial, FOCUS Trial Update and QoL Study Presented at the 2022 ASCO Annual Meeting

Initial results from the Phase 1b portion of the CHOPIN trial of PHP in combination with ipilimumab plus nivolumab in advanced uveal melanoma in seven...

News Image
5 months ago - Delcath Systems, Inc.

Delcath Systems Reports First Quarter 2022 Results and Provides Business Update

NEW YORK , May 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

News Image
5 months ago - Delcath Systems, Inc.

Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

News Image
5 months ago - Delcath Systems, Inc.

Delcath Systems to Host First Quarter 2022 Results

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

News Image
6 months ago - Market News Video

Wednesday 4/13 Insider Buying Report: DCTH, CSPI

News Image
6 months ago - Delcath Systems, Inc.

Delcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conference

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

News Image
6 months ago - Delcath Systems, Inc.

Delcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conference

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...

News Image
6 months ago - Delcath Systems, Inc.

Delcath Systems Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update

NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary...